Direct marketing of pharmaceuticals to consumers

Annual Review of Public Health
Alan Lyles

Abstract

Revised FDA regulations governing pharmaceutical companies' broadcast advertisements directed to consumers produced substantial increases in direct-to-consumer advertising (DTCA) expenditures. Proponents of DTCA claim it supports patient autonomy in the patient-physician relationship and has motivated some consumers to seek a physician's care for conditions they previously had not discussed with a doctor. However, DTCA's blend of promotion and information has produced more prescription drug awareness than knowledge--it has been largely ineffective in educating patients with medical conditions about the medications for those conditions. The evidence for DTCA's increase in pharmaceutical sales is as impressive as is the lack of evidence concerning its impact on the health of the public. Broadcast advertisements are too brief to include extensive technical information; consequently, the impact of FDA regulations to assure a fair balance of risk and benefit in DTCA is still being assessed.

References

Jan 1, 1989·Social Science & Medicine·R K SchwartzJ Avorn
Jan 1, 1987·Bulletin of the Pan American Health Organization
Dec 1, 1980·Biulleten' eksperimental'noĭ biologii i meditsiny·L O BadalianL G Bykova
Feb 1, 1996·Social Science & Medicine·B Chewning, B Sleath
Jan 1, 1997·Medical Care·L R Bradley, J M Zito
Oct 24, 1997·Medical Care·L A MorrisK Gondek
Feb 3, 1999·JAMA : the Journal of the American Medical Association·A F Holmer
Feb 3, 1999·JAMA : the Journal of the American Medical Association·M F Hollon
Aug 8, 1986·Patient Education and Counseling·L W GreenR B Friedman
Jun 3, 1999·PharmacoEconomics·A Lyles, F B Palumbo
May 1, 1997·American Journal of Therapeutics·K I Kaitin
Nov 26, 1999·Journal of General Internal Medicine·R A BellM S Wilkes
Nov 1, 2000·JAMA : the Journal of the American Medical Association·M P Gemperli
Nov 1, 2000·JAMA : the Journal of the American Medical Association·R L Kravitz
May 23, 2001·JAMA : the Journal of the American Medical Association·G K BerlandE A McGlynn
Jan 30, 2002·Clinical Therapeutics·W M Zachry, D B Ginsburg

❮ Previous
Next ❯

Citations

Aug 2, 2011·European Journal of Clinical Pharmacology·Christoph L LassenChristoph H R Wiese
Mar 5, 2004·Clinical Therapeutics·Nithima SumpraditRichard P Bagozzi
Mar 6, 2013·Health Marketing Quarterly·Jin Seong Park, Mariea Grubbs Hoy
Mar 17, 2011·Health Communication·Donald W HelmeKaren J McClanahan
Nov 24, 2011·Journal of Health Communication·Rosemary J AveryKosali I Simon
Aug 22, 2009·Psychology, Health & Medicine·Sean Young, Daniel M Oppenheimer
Apr 15, 2004·Journal of Medical Ethics·S I Saarni, H A Gylling
Apr 11, 2008·BMC Complementary and Alternative Medicine·Kathi J Kemper, Kaylene L Hood
Sep 25, 2012·Research in Social & Administrative Pharmacy : RSAP·Amanda R HarringtonTerri L Warholak
Jul 29, 2006·Journal of Drug Education·Timothy Jon CurryShelley Pacholok
Nov 28, 2006·Journal of the American Dietetic Association·Jeffrey S HamplChristopher M Wharton
Feb 28, 2007·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Semih SeminDilek Guldal
Feb 27, 2013·Pharmacoepidemiology and Drug Safety·Suzanne L WestHelen W Sullivan
Nov 22, 2015·Patient Education and Counseling·Pamela A WilliamsKevin R Betts
May 26, 2007·The American Journal of Medicine·Ziad F Gellad, Kenneth W Lyles
Apr 22, 2006·American Journal of Preventive Medicine·Michael B SteinbergJeffrey L Carson
Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Lewis H Glinert, Jon C Schommer
Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Jon C SchommerRichard A Hansen
Apr 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory A AbelJane C Weeks
Nov 4, 2008·The Journal of Bone and Joint Surgery. American Volume·Jonathan L SchafferJames V Nepola
Jan 12, 2019·Annual Review of Public Health·Sarah E GollustJeff Niederdeppe
Oct 13, 2009·Social Work in Public Health·Pauline Vaillancourt RosenauJay H Glasser
Feb 16, 2006·The Oncologist·Gregory A AbelThomas J Lynch
Sep 1, 2008·Personalized Medicine·Erin E Tracy
May 8, 2020·American Society of Clinical Oncology Educational Book·Fay J HlubockyRandall Holcombe
Feb 22, 2007·Clinical Orthopaedics and Related Research·Sanjo Adeoye, Kevin J Bozic

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Paul C Hébert
The American Journal of Psychiatry
Jonathan M Metzl
© 2022 Meta ULC. All rights reserved